Endothelial dysfunction after stenting and scaffolding of coronary arteries

被引:17
作者
Gori, Tommaso [1 ]
Muenzel, Thomas
机构
[1] Univ Med Ctr Mainz, Dept Cardiol, Mainz, Germany
关键词
Endothelium/vascular type/nitric oxide; pathophysiology; coronary circulation; SIROLIMUS-ELUTING STENT; BALLOON ANGIOPLASTY; IMPLANTATION; RAPAMYCIN; VASOCONSTRICTION; RESTENOSIS; VASOMOTION; OUTCOMES; THERAPY; SYSTEM;
D O I
10.3233/CH-141880
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary artery stenting is associated with endothelial dysfunction, probably caused by the mechanical injury as well as by the tissue reactions triggered by the metal, the polymer and the drug eluted by the stent. The clinical relevance, and the implications, of this dysfunction are still unclear. We revise the iterature on this topic and provide the first evidence regarding endothelial dysfunction after implantation of bioresorbable scaffolds.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 32 条
[1]   Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? [J].
Brugaletta, Salvatore ;
Heo, Jung Ho ;
Garcia-Garcia, Hector M. ;
Farooq, Vasim ;
van Geuns, Robert Jan ;
de Bruyne, Bernard ;
Dudek, Dariusz ;
Smits, Pieter C. ;
Koolen, Jacques ;
McClean, Dougal ;
Dorange, Cecile ;
Veldhof, Susan ;
Rapoza, Richard ;
Onuma, Yoshinobu ;
Bruining, Nico ;
Ormiston, John A. ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2012, 33 (11) :1325-1333
[2]   Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer [J].
Bruns, CJ ;
Koehl, GE ;
Guba, M ;
Yezhelyev, M ;
Steinbauer, M ;
Seeliger, H ;
Schwend, A ;
Hoehn, A ;
Jauch, KW ;
Geissler, EK .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :2109-2119
[3]   Morphological predictors of arterial remodeling in coronary atherosclerosis [J].
Burke, AP ;
Kolodgie, FD ;
Farb, A ;
Weber, D ;
Virmani, R .
CIRCULATION, 2002, 105 (03) :297-303
[4]   Long-term endothelial dysfunction after coronary artery stenting [J].
Caramori, PRA ;
Lima, VC ;
Seidelin, PH ;
Newton, GE ;
Parker, JD ;
Adelman, AG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (06) :1675-1679
[5]   EFFECTS OF ENDOTHELIUM REGENERATION ON CANINE CORONARY-ARTERY FUNCTION [J].
COX, RH ;
HAAS, KS ;
MOISEY, DM ;
TULENKO, TN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :H1681-H1692
[6]   Impaired endothelial vasomotor function after sirolimus-eluting stent implantation [J].
Fuke, Soichiro ;
Maekawa, Kiyoaki ;
Kawamoto, Kenji ;
Saito, Hironori ;
Sato, Tetsuya ;
Hioka, Toru ;
Ohe, Tohru .
CIRCULATION JOURNAL, 2007, 71 (02) :220-225
[7]   Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [J].
Guba, M ;
von Breitenbuch, P ;
Steinbauer, M ;
Koehl, G ;
Flegel, S ;
Hornung, M ;
Bruns, CJ ;
Zuelke, C ;
Farkas, S ;
Anthuber, M ;
Jauch, KW ;
Geissler, EK .
NATURE MEDICINE, 2002, 8 (02) :128-135
[8]   PROLONGED PROLIFERATIVE RESPONSE OF SMOOTH-MUSCLE CELLS AFTER EXPERIMENTAL INTRAVASCULAR STENTING [J].
HANKE, H ;
KAMENZ, J ;
HASSENSTEIN, S ;
OBERHOFF, M ;
HAASE, KK ;
BAUMBACH, A ;
BETZ, E ;
KARSCH, KR .
EUROPEAN HEART JOURNAL, 1995, 16 (06) :785-793
[9]   Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation [J].
Hofma, SH ;
van der Giessen, WJ ;
van Dalen, BM ;
Lemos, PA ;
McFadden, EP ;
Sianos, G ;
Ligthart, JMR ;
van Essen, D ;
de Feyter, PJ ;
Serruys, PW .
EUROPEAN HEART JOURNAL, 2006, 27 (02) :166-170
[10]   Sirolimus-induced vascular dysfunction -: Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation [J].
Jabs, Alexander ;
Goebel, Sebastian ;
Wenzel, Philip ;
Kleschyov, Andrei L. ;
Hortmann, Marcus ;
Oelze, Matthias ;
Daiber, Andreas ;
Muenzel, Thomas .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (22) :2130-2138